Lifeboat Foundation

In 2018, the U.S. Defense Advanced Research Projects Agency (DARPA) announced the multi-million-dollar DARPA Launch Challenge to promote rapid access to space within days rather than years. To earn prizes totaling more than US $12 million, rocket companies would have to launch unfamiliar satellites from two sites in quick succession.

“The launch environment of tomorrow will more closely resemble that of airline operations—with frequent launches from a myriad of locations worldwide,” said Todd Master, DARPA’s program manager for the competition at the time. The U.S. military relies on space-based systems for much of its navigation and surveillance needs, and wants a way to quickly replace damaged or destroyed satellites in the future. At the moment, it takes at least three years to build, test, and launch spacecraft.

To ensure that DARPA was incentivizing the flexible, responsive launch technologies the U.S. military needs, competitors would receive information about the site of their next launch fewer than 30 days prior to each flight, DARPA’s rules stated, and only learn their actual payloads two weeks out.

“A new model based on the blood-vessel network in a rat brain shows that the vessel position within its circulatory network does not influence the blood flow nor how nutrients are transported. Instead, transport is controlled mostly by the dilation of vessels. As well as providing new insights into the circulatory system, the model could lead to better artificial tissues and brain-scanning techniques – and might even improve the performance of solar panels.”

https://physicsworld.com/a/nutrient-flow-in-the-brain-is-con…work-model

If you enjoyed this article, please like and follow our Facebook page for the latest news on neuroscience, psychology, and artificial intelligence:

Continue reading “Nutrient flow in the brain is controlled by blood-vessel dilation, reveals network model” »

Would you consider growing your baby inside an artificial womb?

No matter how cheap or fast paid internet service gets, the Internet of Things (IOT) won’t take wings until we have ubiquitous access to a completely decentralized, open-standard network that does not require a provider subscription. This month, we may be a step closer.

Let’s talk about internet connected gadgets. Not just your phone or PC—and not even a microwave oven or light bulb. Instead, think of everyday objects that are much smaller and much less expensive. Think of things that seemingly have no need to talk with you.

Now think of applications in which these tiny things need to communicate with each other and not just with you. Think of the cost of this “thing” compared to the added cost of continuous communications. Do so many things really need to talk in the first place?

First, there were Trackers…

Continue reading “IOT needs decentralized, long-range connectivity. It’s finally coming” »

It’s sacrificing a rocket in the name of safety.

Antarctica’s native microorganisms are a hearty bunch, able to eke out a living on the planet’s coldest, highest, driest, windiest and emptiest continent. But the region wasn’t always quite as hospitable as it is today.

Photo Credit: Byron Adams

There are lots of exciting companies working in the aging field, and it’s a great time to tell you about some of the more interesting ones. Most of these companies are a while away from human trials yet, but their innovations could possibly be truly game changing.

Underdog Pharmaceuticals is a spin-off company of SENS Research Foundation and is developing a novel approach to treating atherosclerosis.

Atherosclerosis is the number one killer worldwide, and it currently has no totally effective solution. There are three ways in which current medicine tries to address it: Lifestyle changes, including diet and exercise; drugs that slow down the rate of cholesterol accumulation; and interventions such as stents and bypass surgery.

In neurological diseases such as Alzheimer’s disease, Parkinson’s disease or Multiple Sclerosis, brain neurons are constantly being lost, resulting in memory lapses, speech disorders, mood swings and movement disorders, for example, as well as muscle tremors in the case of Parkinson’s. After six years of development, MedUni Vienna researchers from the Department of Neurology (Head: Thomas Berger), led by Roland Beisteiner, have developed a new method of treatment that represents a world first. Using a non-invasive ultrasound technique, it is now possible to reach all areas of the brain and activate neurons that can help to regenerate brain functions. The preliminary data, which have been prominently published on the international stage, show that this can improve brain performance. This has positioned Vienna as a world leader in an important sector of medicine.

The new method is called transcranial pulse stimulation with ultrasound (TPS) and was developed in collaboration with Swiss commercial partner Storz Medical and its project leader, Ernst Marlinghaus. “For the first time in the world, TPS enables us to penetrate into all areas of the brain by means of an ultrasound pulse delivered directly to the skull in a non-invasive, painless procedure, during which the patient is fully conscious, and to specifically target particular areas of the brain and stimulate them,” explains Beisteiner. The study was part of the inter-university cluster led by Roland Beisteiner and Tecumseh Fitch, which is attempting to improve patients’ brain functions by means of brain stimulation and is being jointly run by MedUni Vienna and the University of Vienna. Such clinical procedures must be carried out with great precision and must be tailored to the individual patient. However, the existing electromagnetic techniques such as e.g.

The astronomer missed her Nobel Prize. But she now has a whole new observatory to her name.